Planta Med 1999; 65(3): 218-221
DOI: 10.1055/s-1999-13983
Original Paper

Georg Thieme Verlag Stuttgart · New York

Protopine from Corydalis ternata has Anticholinesterase and Antiamnesic Activities

So Ra Kim1 , Se Young Hwang1 , Young Pyo Jang1 , Mi Jung Park1 , George J. Markelonis2 , Tae Hwan Oh2 , Young Choong Kim1
  • 1College of Pharmacy, Seoul National University, Seoul, Korea
  • 2Department of Anatomy and Neurobiology, University of Maryland, School of Medicine, Baltimore, Maryland, U.S.A.
Further Information

Publication History

July 28, 1998

November 8, 1998

Publication Date:
31 December 1999 (online)

Abstract:

While screening extracts of natural products in search of anticholinesterase activity, we found that a total methanolic extract of the tuber of Corydalis ternata (Papaveraceae) showed significant inhibitory effects on acetylcholinesterase. Further fractionation of this extract using acetylcholinesterase inhibition as the parameter screened resulted in the isolation and purification of an alkaloid, protopine. Protopine inhibited acetylcholinesterase activity in a dose-dependent manner. The concentration required for 50 % inhibition was 50 μM. The anti-acetylcholinesterase activity of protopine was specific, reversible and competitive in manner. Furthermore, when mice were pretreated with protopine, the alkaloid significantly alleviated scopolamine-induced memory impairment. In fact, protopine had an efficacy almost identical to that of velnacrine, a tacrine derivative developed by a major drug manufacturer to treat Alzheimer's disease, at an identical therapeutic concentration. We suggest, therefore, that protopine has both anti-acetylcholinesterase and antiamnesic properties that may ultimately hold significant therapeutic value in alleviating certain memory impairments observed in dementia.

    >